The German Corporate Governance Code (GCGC) is intended to enhance the trust in the management of listed companies and disclose the rules of corporate governance. Both the Executive Management Board and the Supervisory Board of Heidelberg Pharma AG expressly endorse the Code and have implemented it with exceptions.
Statement on Corporate Governance pursuant to Section 289f of the German Commercial Code 2021
The actions of Heidelberg Pharmas' corporate bodies are determined by the principles of good and responsible corporate governance. In this declaration, the Executive Management Board – also acting on behalf of the Supervisory Board – provides its report on corporate governance in the Group pursuant to section 289f of the German Commercial Code (HGB). The current statement of corporate governance can be found here.
Declaration of Conformity
On 29 January 2021, the Executive Management Board and the Supervisory Board of Heidelberg Pharma adopted the declaration of conformity in accordance with Section 161 German Stock Corporation Act. On 6 April 2021 the declaration was modified. This declaration is now valid until the publication of the next declaration of compliance, which is expected at the start of 2022. The modified declaration can be found here.
Current Articles of Association
The current Articles of Association of Heidelberg Pharma of 6 July 2021 can be found here.
Rules of Procedure of the Supervisory Board
The current Rules of Procedure of the Supervisory Board of Heidelberg Pharma as of 14 April 2020 can be found here.
Remuneration system of the Management Board and Supervisory Board
The remuneration system for the Management Board and Supervisory Board of Heidelberg Pharma AG was approved by the Annual General Meeting on May 18, 2021.